Investigation of toll-like receptor (TLR) 4 inhibitor TAK-242 as a new potential anti-rheumatoid arthritis drug
Abstract Background Proper blocking of toll-like receptor (TLR) activation during disease progression has been reported to have inhibitory effect on the pathogenesis of rheumatoid arthritis (RA). We tested whether the TLR4 inhibitor TAK-242 had potential as a remedy for rheumatoid arthritis. Methods...
Main Authors: | Snigdha Samarpita, Joo Young Kim, Mahaboob Khan Rasool, Kyoung Soo Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-01-01
|
Series: | Arthritis Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13075-020-2097-2 |
Similar Items
-
TAK-242 Protects Against Apoptosis in Coronary Microembolization-Induced Myocardial Injury in Rats by Suppressing TLR4/NF-κB Signaling Pathway
by: Xian-tao Wang, et al.
Published: (2017-03-01) -
Effect of TAK-242 on Proliferation and Apoptosis of Human Multiple Myeloma Cells
by: DUAN Pingping, et al.
Published: (2019-04-01) -
Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model
by: Avi Fellner, et al.
Published: (2017-08-01) -
Inhibitive effect of TAK-242 on Tenon’s capsule fibroblasts proliferation in rat eyes
by: Liang Liang, et al.
Published: (2019-11-01) -
TAK-242 ameliorates DSS-induced colitis by regulating the gut microbiota and the JAK2/STAT3 signaling pathway
by: Jiajia Wang, et al.
Published: (2020-08-01)